Skip to content

The effect of a single injection cervical plexus block with 0.375% ropivacaine as part of multimodal analgesia after anterior cervical discectomy and fusion: a randomized controlled trial

The effect of a single injection cervical plexus block with 0.375% ropivacaine as part of multimodal analgesia after anterior cervical discectomy and fusion: a randomized controlled trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20240830003
Enrollment
44
Registered
2024-08-30
Start date
2024-10-21
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with cervical myelopathy who required ACDF surgery. cervical plexus block, multimodal analgesia, postoperative pain control, ACDF surgery.

Interventions

In this group, patients will receive intermediate cervical plexus block under ultrasound guidance for pain control together in addition to other standard analgesic regimen.,In this group, cervical ple
Experimental Procedure/Surgery,No Intervention No treatment
CPB group,Control group

Sponsors

Faculty of Medicine, Khon Kaen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients who plan to undergo 1-3 levels ACDF surgery 2. Age over 18 years 3. ASA physical status 1-3

Exclusion criteria

Exclusion criteria: 1. Refuse to participate 2. Require iliac bone graft harvesting 3. Coagulopathy 4. Allergy to study drugs; paracetamol, fentanyl, morphine, naproxen, or ropivacine 5. Cervical plexus block contraindications include skin infection at the block site, coagulopathy, previous neck surgery, neck radiation, contralateral phrenic nerve paralysis, and patients with severe COPD or other severe respiratory compromises. 6. Inability to cooperate, communicate, or report pain scores.

Design outcomes

Primary

MeasureTime frame
postoperative morphine consumption at PACU, 6h, 12h,24h and 48h total morphine consumption (mg) from IV PCA device

Secondary

MeasureTime frame
postoperative pain score at PACU, 6h, 12h, 24h, and 48h Numeric rating pain score (patient self-report their pain intensity using 11-point scale from 0-10)

Countries

Thailand

Contacts

Public ContactIntuorn Artphom

Faculty of Medicine, Khon Kaen University

intuart@kku.ac.th66959714525

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026